hefei tnj chemical industry

Reboxetine Mesylate CAS 98769-84-7 - China Manufacturer & Suppliers

Reboxetine mesylate, known by its CAS number 98769-84-7, is a potent norepinephrine reuptake inhibitor used primarily in the treatment of depression. As a dedicated supplier based in China, I am excited to offer high-quality Reboxetine mesylate with the chemical formula C20H27NO6S. We ensure competitive pricing and reliable sourcing from trusted manufacturers. When considering where to buy Reboxetine mesylate, our factory stands out for our commitment to quality and safety in production processes. We understand the importance of timely delivery and transparent communication. If you are a B2B purchaser in need of a reputable Reboxetine mesylate supplier, you're in the right place. I’m here to support your procurement needs and help you meet your business objectives. Don’t hesitate to reach out for the best prices and reliable supply options tailored to your requirements.

Hot Selling Product

CAS 98769-84-7,Buy Reboxetine mesylate, C20H27NO6S,Reboxetine mesylate price, Reboxetine mesylate suppliers, Reboxetine mesylate factory, Reboxetine mesylate manufacturers in 2025 Outperforms the Competition

In the rapidly evolving world of pharmaceuticals, Reboxetine mesylate (CAS 98769-84-7) has carved out a significant niche for itself, particularly for those involved in global sourcing. This compound, characterized by its molecular formula C20H27NO6S, is increasingly recognized for its compelling therapeutic properties and robust application in the treatment of depression and anxiety disorders. As we look towards 2025, the demand for high-quality Reboxetine mesylate is anticipated to surge, presenting an excellent opportunity for buyers to secure a reliable source of this vital pharmaceutical ingredient. What sets certain suppliers and manufacturers apart in the competitive landscape is their commitment to quality and innovation. Businesses focusing on the production of Reboxetine mesylate offer not only competitive pricing but also ensure compliance with international standards and regulations. This commitment to excellence, combined with efficient supply chain management, allows them to deliver superior products to global markets. Buyers should seek out manufacturers with a proven track record of reliability, transparency, and responsiveness to customer needs. As the market evolves, choosing the right supplier for Reboxetine mesylate will be crucial for maintaining a competitive edge. In conclusion, the future of Reboxetine mesylate looks promising as it becomes more prominent in pharmaceutical formulations. For global purchasers, identifying reputable and forward-thinking suppliers will be key to accessing this essential compound. With the right partners, businesses can not only meet the rising demand but also contribute to the advancing landscape of mental health treatments. As 2025 approaches, now is the time to explore the potential of Reboxetine mesylate and secure advantageous partnerships that outperform the competition.

Reboxetine Mesylate Data Overview

Property Details
CAS Number 98769-84-7
Molecular Formula C20H27NO6S
Molecular Weight 399.56 g/mol
Appearance White to off-white powder
Melting Point Approximately 130-140 °C
Solubility Soluble in water and methanol
Storage Conditions Store in a cool, dry place
Application Used as an antidepressant
Market Growth Rate (2025) Projected increase of 10% CAGR

Related Products

buy erythritol powder crystal from hefei tnj chemical

CAS 98769-84-7,Buy Reboxetine mesylate, C20H27NO6S,Reboxetine mesylate price, Reboxetine mesylate suppliers, Reboxetine mesylate factory, Reboxetine mesylate manufacturers Sets the Industry Standard Winning in 2025

Global Market Overview of Reboxetine Mesylate (2023)

The chart above illustrates the global market share distribution of Reboxetine Mesylate across different regions as of 2023. North America holds the largest market share at 30%, attributed to its advanced healthcare infrastructure and higher prescription rates for antidepressants. Europe follows closely with a 25% share, as ongoing research and development in psychopharmacology bolster its usage. Meanwhile, Asia dominates with a significant 35% share, driven by the increasing prevalence of mental health awareness and the growing population. South America and Africa account for smaller segments, each holding approximately 5% of the market. This data indicates varied pharmacological trends and emphasizes strategic focus areas for industry stakeholders aiming to enhance their offerings and market reach in the years ahead.

Top Selling Products